Dyspnea
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases
|
Sign or Symptom
|
222
|
26
|
0.100 |
None |
|
0 |
|
|
|
Coughing
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases
|
Sign or Symptom
|
235
|
16
|
0.100 |
None |
|
0 |
|
|
|
Pulmonary venous occlusion
|
phenotype |
|
Finding
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
2-oxo-hept-3-ene-1,7-dioate hydratase activity
|
phenotype |
|
Molecular Function
|
14
|
|
0.300 |
strong |
1.000 |
1 |
|
2018 |
2018 |
Pulmonary Hypertension
|
phenotype |
Respiratory Tract Diseases
|
Pathologic Function
|
156
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Amino Acid Metabolism, Inborn Errors
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
20
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Familial pulmonary arterial hypertension
|
disease |
|
Disease or Syndrome
|
12
|
1
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Myopathy
|
group |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
634
|
166
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Immune System Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
451
|
116
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Amino Acid Metabolism, Inherited Disorders
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hair Diseases
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
17
|
2
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Finding of body mass index
|
phenotype |
|
Finding
|
88
|
252
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Body mass index procedure
|
phenotype |
|
Diagnostic Procedure
|
88
|
252
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Dehydroepiandrosterone sulfate measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
18
|
27
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Reticulocyte count (procedure)
|
phenotype |
|
Laboratory Procedure
|
234
|
474
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Memory impairment
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
763
|
48
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Non-alcoholic Fatty Liver Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1058
|
222
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |